NEUROPRO Trademark

Trademark Overview


On Monday, March 11, 2013, a trademark application was filed for NEUROPRO with the United States Patent and Trademark Office. The USPTO has given the NEUROPRO trademark a serial number of 85872878. The federal status of this trademark filing is ABANDONED - AFTER EX PARTE APPEAL as of Tuesday, November 25, 2014. This trademark is owned by Neurodyn Inc.. The NEUROPRO trademark is filed in the Pharmaceutical Products category with the following description:

Herbal supplements containing ginseng and ginsenocides, in tablet, capsule, gel, powder or liquid form, for both the prevention and treatment of neurodegenerative diseases, namely, Parkinson's disease, Alzheimer's disease, and Amyotrophic lateral sclerosis, and the treatment of spinal cord injury, brain injury, promotion and maintenance of healthy neurons, memory, and cognitive function; Nutritional supplements containing ginseng, in tablet, capsule, gel, powder or liquid form, for both the prevention and treatment of neurodegenerative diseases, namely, Parkinson's disease, Alzheimer's disease, and Amyotrophic lateral sclerosis, and the treatment of spinal cord injury, brain injury, promotion and maintenance of healthy neurons, memory, and cognitive function; Nutritional supplements containing ginseng and omega-3 fatty acids, in tablet, capsule, gel, powder or liquid form, for both the prevention and treatment of neurodegenerative diseases, namely, Parkinson's disease, Alzheimer's dise...
neuropro

General Information


Serial Number85872878
Word MarkNEUROPRO
Filing DateMonday, March 11, 2013
Status603 - ABANDONED - AFTER EX PARTE APPEAL
Status DateTuesday, November 25, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesHerbal supplements containing ginseng and ginsenocides, in tablet, capsule, gel, powder or liquid form, for both the prevention and treatment of neurodegenerative diseases, namely, Parkinson's disease, Alzheimer's disease, and Amyotrophic lateral sclerosis, and the treatment of spinal cord injury, brain injury, promotion and maintenance of healthy neurons, memory, and cognitive function; Nutritional supplements containing ginseng, in tablet, capsule, gel, powder or liquid form, for both the prevention and treatment of neurodegenerative diseases, namely, Parkinson's disease, Alzheimer's disease, and Amyotrophic lateral sclerosis, and the treatment of spinal cord injury, brain injury, promotion and maintenance of healthy neurons, memory, and cognitive function; Nutritional supplements containing ginseng and omega-3 fatty acids, in tablet, capsule, gel, powder or liquid form, for both the prevention and treatment of neurodegenerative diseases, namely, Parkinson's disease, Alzheimer's disease, and Amyotrophic lateral sclerosis, and the treatment of spinal cord injury, brain injury, promotion and maintenance of healthy neurons, memory, and cognitive function; Nutritional supplements containing ginsenocides, in tablet, capsule, gel, powder or liquid form, for both the prevention and treatment of neurodegenerative diseases, namely, Parkinson's disease, Alzheimer's disease, and Amyotrophic lateral sclerosis, and the treatment of spinal cord injury, brain injury, promotion and maintenance of healthy neurons, memory, and cognitive function; Nutritional supplements containing ginsenocides and omega-3 fatty acids, in tablet, capsule, gel, powder or liquid form, for both the prevention and treatment of neurodegenerative diseases, namely, Parkinson's disease, Alzheimer's disease, and Amyotrophic lateral sclerosis, and the treatment of spinal cord injury, brain injury, promotion and maintenance of healthy neurons, memory, and cognitive function; Nutritional supplements containing ginseng extract, in tablet, capsule, gel, powder or liquid form, for both the prevention and treatment of neurodegenerative diseases, namely, Parkinson's disease, Alzheimer's disease, and Amyotrophic lateral sclerosis, and the treatment of spinal cord injury, brain injury, promotion and maintenance of healthy neurons, memory, and cognitive function; Nutritional supplements containing ginseng extract and omega-3 fatty acids, in tablet, capsule, gel, powder or liquid form, for both the prevention and treatment of neurodegenerative diseases, namely, Parkinson's disease, Alzheimer's disease, and Amyotrophic lateral sclerosis, and the treatment of spinal cord injury, brain injury, promotion and maintenance of healthy neurons, memory, and cognitive function; medical food supplements in powdered, liquid and tablet form for the prevention and treatment of neurodegenerative disease, Alzheimer's disease, Parkinson's disease, and Amyotrophic lateral sclerosis; medical food for the treatment of spinal cord injury and brain injury; medical food supplements in powdered, liquid and tablet form; medical food supplements in powdered, liquid and tablet form for use in the dietary management of patients with neurodegenerative diseases, Alzheimer's disease, Parkinson's disease, Amyotrophic lateral sclerosis, spinal cord injury, and brain injury; ginseng, ginsenocides and omega-3 fatty acids for the dietary management of neurodegenerative disease, Alzheimer's disease, Parkinson's disease, Amyotrophic lateral sclerosis, spinal cord injury, and brain injury
Pseudo MarkNEURO PRO; NEUROLOGICAL PRO

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 15, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNeurodyn Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressVancouver, BC V6E4A2
CA

Trademark Events


Event DateEvent Description
Tuesday, December 2, 2014ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Tuesday, November 25, 2014ABANDONMENT - AFTER EX PARTE APPEAL
Tuesday, November 25, 2014EXPARTE APPEAL TERMINATED
Thursday, October 16, 2014EXPARTE APPEAL DSMSED - FAILURE TO FILE BRIEF
Tuesday, July 22, 2014NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Tuesday, July 22, 2014ACTION DENYING REQ FOR RECON E-MAILED
Tuesday, July 22, 2014ACTION CONTINUING FINAL - COMPLETED
Tuesday, July 15, 2014DIVISIONAL PROCESSING COMPLETE
Thursday, July 10, 2014DIVISIONAL REQUEST RECEIVED
Tuesday, July 15, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 14, 2014JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, July 14, 2014EX PARTE APPEAL-INSTITUTED
Monday, July 14, 2014EXPARTE APPEAL RECEIVED AT TTAB
Friday, July 11, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 10, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 10, 2014TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, July 10, 2014TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, January 14, 2014NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, January 14, 2014FINAL REFUSAL E-MAILED
Tuesday, January 14, 2014FINAL REFUSAL WRITTEN
Tuesday, December 24, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 23, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 23, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 24, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 24, 2013NON-FINAL ACTION E-MAILED
Monday, June 24, 2013NON-FINAL ACTION WRITTEN
Thursday, June 20, 2013ASSIGNED TO EXAMINER
Saturday, March 16, 2013NOTICE OF PSEUDO MARK E-MAILED
Friday, March 15, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, March 14, 2013NEW APPLICATION ENTERED IN TRAM